Satiety, Meal Frequency and Nutritional Aspects

NCT ID: NCT01573988

Last Updated: 2012-09-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

37 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-08-31

Study Completion Date

2012-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, the investigators are interested in assessing the effects of the isocaloric increase of eating frequency on appetite and metabolism. How the consumption of an isocaloric breakfast in four intakes vs. one can modify satiety and appetite control in lean and obese subjects through :

* the physiological consequences : difference in postprandial kinetics of glucose, non esterified fatty acid, triglyceride, the secretion of satiety gut hormone (insulin, ghrelin, leptin and cholescystokinine (CCK), peptide YY (PYY), glucagon-like peptide-1 (GLP-1), nutrients oxidative fate and plasmatic oxidative stress (Malondialdehyde (MDA), glutathion, lipid hydroperoxides)
* eating behavior during an ad libitum buffet test meal

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Volunteers

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Nutrition Eating frequency Food intake Eating behavior Satiety Ghrelin

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

non-obese volunteers

Volunteers with a BMI (Body Mass Index) between 20 and 25 kg/m2.

Group Type OTHER

Increasing eating frequency

Intervention Type OTHER

The subjects receive the same breakfast with two sequences :

* breakfast in one intake at 8:00
* breakfast in four isocaloric intakes (8:00, 9:00, 10:00, 11:00) The sequence made twice : one for metabolic study and one for the study of eating behavior

The lunch during metabolic study is a standard meal The lunch during behavioural study is an ad libitum buffet test meal.

The administration order is determined by randomized allocation. The wash-out period is one to three weeks.

There are not diet or exercise interventions.

Obese volunteers

Volunteers with a BMI (Body Mass Index) between 30 and 35 kg/m2.

Group Type OTHER

Increasing eating frequency

Intervention Type OTHER

The subjects receive the same breakfast with two sequences :

* breakfast in one intake at 8:00
* breakfast in four isocaloric intakes (8:00, 9:00, 10:00, 11:00) The sequence made twice : one for metabolic study and one for the study of eating behavior

The lunch during metabolic study is a standard meal The lunch during behavioural study is an ad libitum buffet test meal.

The administration order is determined by randomized allocation. The wash-out period is one to three weeks.

There are not diet or exercise interventions.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Increasing eating frequency

The subjects receive the same breakfast with two sequences :

* breakfast in one intake at 8:00
* breakfast in four isocaloric intakes (8:00, 9:00, 10:00, 11:00) The sequence made twice : one for metabolic study and one for the study of eating behavior

The lunch during metabolic study is a standard meal The lunch during behavioural study is an ad libitum buffet test meal.

The administration order is determined by randomized allocation. The wash-out period is one to three weeks.

There are not diet or exercise interventions.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* No smokers
* BMI 20 to 35 kg/m2
* Moderate physical activity
* Safety during medical consultation
* Feeding behavioural phenotype (Dutch Eating Questionnaire, Three Eating Factor Questionnaire)

Exclusion Criteria

* Medical history which may affect glucose metabolism (diabetes, renal or hepatic failure, thyroid dysfunction, Cushing syndrome, acromegaly…)
* Medical history which affect nutrient absorption (gastro-intestinal and pancreatic disease, gastrectomy, colectomy…)
* Drug use in the last two months that could affect glucose metabolism (steroids, topical gastric preparation, anorectic drugs…)
* Eating disorders
* Claustrophobic subjects
Minimum Eligible Age

20 Years

Maximum Eligible Age

40 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospices Civils de Lyon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Hospitalier Lyon Sud - Centre de Recherche en Nutrition Humaine

Pierre-Bénite, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2010.612/16

Identifier Type: -

Identifier Source: org_study_id